ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,256Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 324

$1.13M Total Retail Price of All Prescriptions

Rank: 9 out of 324

444 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 444 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 11,261 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
AMLODIPINE BESYLATE 612 601 1 4
SIMVASTATIN 580 526 2 1
LEVOTHYROXINE SODIUM 539 517 3 2
LOSARTAN POTASSIUM 401 384 4 15
WARFARIN SODIUM 344 303 5 10
OMEPRAZOLE 304 290 6 6
LISINOPRIL 269 261 7 3
HYDROCHLOROTHIAZIDE 249 245 8 11
FUROSEMIDE 243 222 9 7
HYDROCODONE-ACETAMINOPHEN 242 188 S3 10 5
PANTOPRAZOLE SODIUM 212 200 11 34
POTASSIUM CHLORIDE 208 197 12 8
GABAPENTIN 205 154 13 13
ATORVASTATIN CALCIUM 204 188 14 12
CITALOPRAM HBR 194 183 15 16
LOSARTAN-HYDROCHLOROTHIAZIDE 193 172 16 44
METOPROLOL TARTRATE 186 178 17 14
METFORMIN HCL 177 153 18 9
ALENDRONATE SODIUM 167 166 19 24
CARVEDILOL 164 163 20 22
ATENOLOL 160 155 21 18
CRESTOR 142 139 22 28
METOPROLOL SUCCINATE 110 110 23 17
ALLOPURINOL 110 110 23 27
PRAVASTATIN SODIUM 102 102 25 21
NAMENDA 101 101 26 31
FENOFIBRATE 99 99 27 79
FELODIPINE ER 93 87 28 158
LANTUS 91 66 29 39
SERTRALINE HCL 85 85 30 23
ACTONEL 84 59 31 256
MONTELUKAST SODIUM 83 73 32 143
TRAMADOL HCL 83 82 32 19
TAMSULOSIN HCL 82 82 34 26
SYNTHROID 78 78 35 30
METOCLOPRAMIDE HCL 76 65 36 125
MELOXICAM 76 76 36 29
NEXIUM 72 58 38 33
TRICOR 72 62 38 126
GLIMEPIRIDE 72 72 38 37
DIOVAN 70 69 41 56
CLOPIDOGREL 68 59 42 38
SINGULAIR 66 59 43 92
BENAZEPRIL HCL 65 65 44 75
FLUTICASONE PROPIONATE 64 62 45 32
NIASPAN 63 54 46 123
LANTUS SOLOSTAR 62 55 47 85
OXYBUTYNIN CHLORIDE 62 51 47 88
POLYETHYLENE GLYCOL 3350 60 60 49 49
SPIRONOLACTONE 58 42 50 47
AMLODIPINE BESYLATE-BENAZEPRIL 58 46 50 100
ZOLPIDEM TARTRATE 56 50 52 20
DIOVAN HCT 54 54 53 148
HUMALOG 53 44 54 103
PEN NEEDLE 50 47 55 146
FLUOXETINE HCL 50 48 55 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.